PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'The Israel Centre for Disease Control, Israel Ministry of Health, Tel Hashomer, Ramat Gan, Israel; Department of Epidemiology and Preventive Medicine, School of Public Health, Tel Aviv University Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel. Electronic address: aharona.freedman@moh.gov.il.\', \'The Israel Centre for Disease Control, Israel Ministry of Health, Tel Hashomer, Ramat Gan, Israel; Department of Epidemiology and Preventive Medicine, School of Public Health, Tel Aviv University Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel.\', \'The Israel Centre for Disease Control, Israel Ministry of Health, Tel Hashomer, Ramat Gan, Israel.\', \'The Israel Centre for Disease Control, Israel Ministry of Health, Tel Hashomer, Ramat Gan, Israel; School of Public Health, Haifa University, Haifa, Israel.\']
?:citedBy
  • -1
?:creator
?:doi
?:doi
  • S2352-3964(21)00367-410.1016/j.ebiom.2021.103574
?:hasPublicationType
?:journal
  • EBioMedicine
is ?:pmid of
?:pmid
?:pmid
  • 34537449
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • 2.895
?:rankingScore_hIndex
  • 26
?:title
  • The BNT162b2 vaccine effectiveness against new COVID-19 cases and complications of breakthrough cases: A nation-wide retrospective longitudinal multiple cohort analysis using individualised data.
?:type
?:year
  • 2021

Metadata

Anon_0  
expand all